Phosphorylated P-RPS6 induces DNA damage triggered by the expression of the mutant KRAS and reduces p53-mediated tumor suppression which reveals that p-RPS6 is an important target in pancreatic cancer at initial stages [104]. This evidence concerns the gene TP53 and familial pancreatic carcinoma.